Phase 3 Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Your cancer diagnosis has been confirmed through a tissue or cell sample (biopsy or similar test).
- You are willing and able to sign a consent form agreeing to take part in the trial.
- You are over 18 years old and your doctors estimate you are likely to live for more than 3 months.
- Your liver is functioning at a certain level, as measured by standard medical scoring systems (confirm with trial site).
- Your blood's ability to clot is either normal or can be corrected to a safe level.
- Your recent blood test results (taken within 7 days before the procedure) show that your blood counts, kidney function, liver function, and other markers are within acceptable ranges (confirm with trial site for specific values).
- You have at least one tumour that can be measured using standard imaging guidelines.
- You are using or willing to use appropriate birth control during the trial.
- You are able and willing to attend scheduled visits, follow the treatment plan, and complete required tests.
Who may not be able to join:
- You have taken part in another clinical trial for a drug or medical device in the last 4 weeks.
- You have fluid build-up in your abdomen (ascites), brain problems caused by liver disease (hepatic encephalopathy), or bleeding from swollen veins in your stomach or throat.
- You have another serious illness, such as significant heart disease, poorly controlled diabetes, or a psychiatric condition, that could affect the trial results.
- You have or have previously had another type of cancer.
- You are currently pregnant or breastfeeding.
- You are unlikely to follow the trial's requirements or attend appointments as needed.
- You have blood clotting levels, kidney problems requiring dialysis, severe hardening of the arteries, or uncontrolled high blood pressure (above 160/100 mmHg) that would make the procedure used in this trial unsafe.
- You are allergic to contrast dye (the liquid used in imaging scans).
- You are taking medications that could interfere with how the study drugs are absorbed or processed by your body.
- The trial doctor has determined for any other reason that the trial may not be appropriate for you.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Zhenfeng Zhang, MD,PhD, Second Affiliated Hospital of Guangzhou Medical University
Phone: 02034153532
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Overall survival; Complete response (CR) rate before or at Month 6
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.